김혜련 (연세대학교 의과대학)님 | 한빛사연구자 > 한빛사

연세대학교 의과대학

CV File

종양의학

최종업데이트 2025.01.03.

4-1BB+ Tregs and inhibitory progenitor exhausted T cells confer resistance to anti-PD-L1 and anti-CTLA-4 combination therapy
- Cell Rep. Med., Oct 03 2025, S2666-3791(25)00481-1 | https://doi.org/10.1016/j.xcrm.2025.102408
- 2025-10
- 한빛사논문
[LETTER TO THE JOURNAL]Comparative single-cell analysis of esophageal cancer subtypes reveals tumor microenvironment distinctions explaining varied immunotherapy responses
- Cancer Commun., Jun 28 2025, | https://doi.org/10.1002/cac2.70046
- 2025-06
- 생명과학
- 한빛사논문
[LETTER TO THE JOURNAL] Single-cell multi-omics reveals tumor microenvironment factors underlying poor immunotherapy responses in ALK-positive lung cancer
- Cancer Commun., Jan 04 2025, | https://doi.org/10.1002/cac2.12658
- 2025-01
- 생명과학
- 한빛사논문
A conserved pilin from uncultured gut bacterial clade TANB77 enhances cancer immunotherapy
- Nat. Commun., Dec 27 2024, 15 (1) 10726 | https://doi.org/10.1038/s41467-024-55388-3
- 2024-12
- 의약학
- 한빛사논문
Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer
- Exp Mol Med ., Sep 2020, 52 (9) | https://doi.org/10.1038/s12276-020-00493-8
- 2020-09
- 의약학
- 상위피인용논문
Lazertinib in EGFR-Variant Non-Small Cell Lung Cancer With CNS Failure to Prior EGFR Tyrosine Kinase Inhibitors: A Nonrandomized Controlled Trial
- JAMA Oncol., Aug 15 2024, | https://doi.org/10.1001/jamaoncol.2024.2640
- 2024-08
- 의약학
- 한빛사논문
Single-cell analysis reveals cellular and molecular factors counteracting HPV-positive oropharyngeal cancer immunotherapy outcomes
- J. Immunother. Cancer, Jun 10 2024, 12 (6) e008667 | https://doi.org/10.1136/jitc-2023-008667
- 2024-06
- 생명과학
- 한빛사논문
A phase II open-label randomized clinical trial of preoperative durvalumab or durvalumab plus tremelimumab in resectable head and neck squamous cell carcinoma
- Clin. Cancer Res., Mar 08 2024, | https://doi.org/10.1158/1078-0432.CCR-23-3249
- 2024-03
- 의약학
- 한빛사논문
Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial.
- J. Clin. Oncol., Sep 12 2023 | https://doi.org/10.1200/JCO.22.02786
- 2023-09
- 의약학
- 한빛사논문
Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation
- Theranostics, Published 2022-5-1, 12(8):3676-3689 | doi:10.7150/thno.72511
- 2022-05
- 바이오·의료융합
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기